CollPlant Biotechnologies (FRA:CPT) Other Current Liabilities : €1.14 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Other Current Liabilities?

CollPlant Biotechnologies's other current liabilities for the quarter that ended in Dec. 2024 was €1.14 Mil.

CollPlant Biotechnologies's quarterly other current liabilities increased from Jun. 2024 (€0.00 Mil) to Sep. 2024 (€0.00 Mil) and increased from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€1.14 Mil).

CollPlant Biotechnologies's annual other current liabilities increased from Dec. 2022 (€1.31 Mil) to Dec. 2023 (€1.41 Mil) but then declined from Dec. 2023 (€1.41 Mil) to Dec. 2024 (€1.14 Mil).

CollPlant Biotechnologies Other Current Liabilities Historical Data

The historical data trend for CollPlant Biotechnologies's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Other Current Liabilities Chart

CollPlant Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

0.85

1.18

1.31

1.41

1.14

CollPlant Biotechnologies Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Current Liabilities	Get a 7-Day Free Trial															1.41	-	-	-	1.14

CollPlant Biotechnologies Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

CollPlant Biotechnologies Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (FRA:CPT) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

CLGN:USA

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.